Stock Analiz

Tandem Diabetes Care Inc. (TNDM) stock forecast and price target

Price $20.07 · data as of November 13, 2026

12-month price target

Average target$26.90
Upside / downside+34.1%
Analysts21
ConsensusBuy
Low $18.00Average $26.90High $50.00

Gold marker: average target · white marker: today’s price ($20.07)

Analyst ratings

Strong buy 2Buy 11Hold 12Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-0.60+76.7%$1.1B
Next fiscal year
ends December 31, 2027
$0.10+115.8%$1.2B
Next quarter
ends December 31, 2026
$0.11+1169.7%$292M
Quarter after
ends March 31, 2027
$-0.15+51.6%$264M

Consensus of the analysts covering Tandem Diabetes Care, updated daily. In the last 30 days 0 estimates were raised and 4 lowered.

Our model vs. Wall Street

Analysts see 34.1% upside over 12 months. Our discounted cash flow model with moderate assumptions puts Tandem Diabetes Care’s intrinsic value about 74% below today’s market value, and it scores 0.4 out of 5 on our checks. Price targets follow sentiment; a DCF follows cash. When both point the same way the signal is stronger. Try your own assumptions.

Frequently asked questions

What is the Tandem Diabetes Care stock price target?

The average 12-month target from 21 analysts is $26.90, 34.1% above the current price of $20.07 Targets range from $18.00 to $50.00.

Is Tandem Diabetes Care a buy according to analysts?

The consensus rating is “Buy” (2 strong buy, 11 buy, 12 hold). Ratings are opinions, not guarantees; this is not investment advice.

How much is Tandem Diabetes Care expected to earn?

Analysts expect EPS of $-0.60 for the fiscal year ending December 31, 2026 and $0.10 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.